These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2182146)

  • 41. Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state.
    Ariëns RA; de Lange M; Snieder H; Boothby M; Spector TD; Grant PJ
    Lancet; 2002 Feb; 359(9307):667-71. PubMed ID: 11879863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The hypercoagulable states.
    Schafer AI
    Ann Intern Med; 1985 Jun; 102(6):814-28. PubMed ID: 3158262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemostatic study before onset of disseminated intravascular coagulation.
    Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi A; Mori Y; Deguchi K
    Am J Hematol; 1993 Jul; 43(3):190-4. PubMed ID: 8352234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
    Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy evaluation of D-dimer and modified criteria in overt and nonovert disseminated intravascular coagulation diagnosis.
    Li WJ; Sha M; Ma W; Zhang ZP; Wu YJ; Shi DM
    Int J Lab Hematol; 2016 Apr; 38(2):151-9. PubMed ID: 26833979
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blood coagulation and fibrinolytic factors and their inhibitors in critically ill patients.
    Hellgren M; Egberg N; Eklund J
    Intensive Care Med; 1984; 10(1):23-8. PubMed ID: 6559831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hypercoagulability during pregnancy: evidences for a thrombophilic state].
    Maiello M; Torella M; Caserta L; Caserta R; Sessa M; Tagliaferri A; Bernacchi M; Napolitano M; Nappo C; De Lucia D; Panariello S
    Minerva Ginecol; 2006 Oct; 58(5):417-22. PubMed ID: 17006429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. D-dimer: An Overview of Hemostasis and Fibrinolysis, Assays, and Clinical Applications.
    Olson JD
    Adv Clin Chem; 2015; 69():1-46. PubMed ID: 25934358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. D-dimer concentrations in healthy dogs and dogs with disseminated intravascular coagulation.
    Stokol T; Brooks MB; Erb HN; Mauldin GE
    Am J Vet Res; 2000 Apr; 61(4):393-8. PubMed ID: 10772103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum des-R prothrombin activation peptide fragment 2: a novel prognostic marker for disseminated intravascular coagulation.
    Chung S; Kim JE; Kim HK; Yeon EH; Shin YS; Kim CW
    Thromb Res; 2013 Jun; 131(6):547-53. PubMed ID: 23664563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
    Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
    Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
    Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states.
    López Y; Paloma MJ; Rifón J; Cuesta B; Páramo JA
    Thromb Res; 1999 Jan; 93(2):71-8. PubMed ID: 9950260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monoclonal antibody-based plasma assays for fibrin(ogen) and derivatives, and their clinical relevance.
    Kroneman H; Nieuwenhuizen W; Knot EA
    Blood Coagul Fibrinolysis; 1990; 1(1):91-111. PubMed ID: 2102791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma levels of activated protein C-protein C inhibitor complex in patients with hypercoagulable states.
    Watanabe R; Wada H; Sakakura M; Mori Y; Nakasaki T; Okugawa Y; Gabazza EC; Hayashi T; Nishioka J; Suzuki K; Shiku H; Nobori T
    Am J Hematol; 2000 Sep; 65(1):35-40. PubMed ID: 10936861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of the fibrinolytic state by measuring stable cross-linked fibrin degradation products in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
    Okajima K; Koga S; Okabe H; Inoue M; Takatsuki K
    Acta Haematol; 1989; 81(1):15-8. PubMed ID: 2494830
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fibrin formation and degradation in patients with arteriosclerotic disease.
    Herren T; Stricker H; Haeberli A; Do DD; Straub PW
    Circulation; 1994 Dec; 90(6):2679-86. PubMed ID: 7994808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coagulation activation in patients with Binswanger disease.
    Tomimoto H; Akiguchi I; Wakita H; Osaki A; Hayashi M; Yamamoto Y
    Arch Neurol; 1999 Sep; 56(9):1104-8. PubMed ID: 10488811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coagulation system activated in Duchenne muscular dystrophy patients with cardiac dysfunction.
    Saito T; Yamamoto Y; Matsumura T; Nozaki S; Fujimura H; Shinno S
    Brain Dev; 2005 Sep; 27(6):415-8. PubMed ID: 16122628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.